Mitsubishi Introduces New Plastic Syringe and Vial for Parenteral Pharmaceuticals

May 21, 2015
Pharmaceutical Technology Editors

OXY-CAPT brings together properties of plastic and glass containers through the combination of oxygen absorption and cyclic olefin copolymer (COP) high barrier layers.

Mitsubishi Gas Chemical Company, Tokyo, Japan, has introduced OXY-CAPT, the new, advanced material, multilayer plastic syringe and vial for parenteral pharmaceuticals.

OXY-CAPT brings together properties of plastic and glass containers through the combination of oxygen absorption and cyclic olefin copolymer (COP) high barrier layers. The container is manufactured with three layers: water barrier layer-COP resin; oxygen barrier layer-new oxygen-absorbing layer; drug contact and water barrier layer-COP resin.

The key features of OXY-CAPT include its oxygen barrier, which the company claims has the lowest measurable oxygen permeability levels, and the low water barrier vapor permeability values. Moreover, inorganic low molecular weight extractable levels are below Type I glass. The oxygen barrier maintains glass-like clarity over time while the container has a lighter weight than glass with high resistance to breakage, thereby enabling easier handling and lower shipping cost. OXY-CAPT is said to have low protein adsorption; glass-like transparency; reduced total amount of silicone oil; and easy disposal. Plunger and plunger rod are included and customizable according to customer requirements.